Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Knipe

Showing results (101-110 of 159) with videos related to

Pageof 16
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|May 11, 2011
Herpesviral replication compartments move and coalesce at nuclear speckles to enhance export of viral late mRNALynne Chang, William J Godinez, Il-Han Kim, et al.
Vaccine|June 21, 2008
Comparison of immunogenicity and protective efficacy of genital herpes vaccine candidates herpes simplex virus 2 dl5-29 and dl5-29-41L in mice and guinea pigsYo Hoshino, Lesley Pesnicak, Kennichi C Dowdell, et al.
Journal of Virology|December 15, 2004
Comparative efficacy and immunogenicity of replication-defective, recombinant glycoprotein, and DNA vaccines for herpes simplex virus 2 infections in mice and guinea pigsYo Hoshino, Sarat K Dalai, Kening Wang, et al.
The Journal of Infectious Diseases|February 3, 2005
The role of toll-like receptors in herpes simplex infection in neonatesEvelyn A Kurt-Jones, John Belko, Catherine Yu, et al.
Virology|June 24, 2016
Production of immunogenic West Nile virus-like particles using a herpes simplex virus 1 recombinant vectorTravis J Taylor, Fernando Diaz, Robert C Colgrove, et al.
Virology Journal|October 28, 2004
Persistent expression of chemokine and chemokine receptor RNAs at primary and latent sites of herpes simplex virus 1 infectionW James Cook, Martha F Kramer, Russell M Walker, et al.
Immunology|July 22, 2015
Combined cytotoxic activity of an infectious, but non-replicative herpes simplex virus type 1 and plasmacytoid dendritic cells against tumour cellsSabrina Thomann, Jan B Boscheinen, Karin Vogel, et al.
Journal of Virology|February 26, 2010
Numerous conserved and divergent microRNAs expressed by herpes simplex viruses 1 and 2Igor Jurak, Martha F Kramer, Joseph C Mellor, et al.
Virology|November 8, 2015
History and genomic sequence analysis of the herpes simplex virus 1 KOS and KOS1.1 sub-strainsRobert C Colgrove, Xueqiao Liu, Anthony Griffiths, et al.
Immunotherapy Advances|July 18, 2023
Blockade of innate inflammatory cytokines TNF<b>α</b>, IL-1<b>β</b>, or IL-6 overcomes virotherapy-induced cancer equilibrium to promote tumor regressionMichael J Walsh, Lestat R Ali, Patrick Lenehan, et al.
Pageof 16

Showing results (101-110 of 159) with videos related to

Sort By:
Pageof 16
Proceedings of the National Academy of Sciences of the United States of America|May 11, 2011
Herpesviral replication compartments move and coalesce at nuclear speckles to enhance export of viral late mRNALynne Chang, William J Godinez, Il-Han Kim, et al.
Vaccine|June 21, 2008
Comparison of immunogenicity and protective efficacy of genital herpes vaccine candidates herpes simplex virus 2 dl5-29 and dl5-29-41L in mice and guinea pigsYo Hoshino, Lesley Pesnicak, Kennichi C Dowdell, et al.
Journal of Virology|December 15, 2004
Comparative efficacy and immunogenicity of replication-defective, recombinant glycoprotein, and DNA vaccines for herpes simplex virus 2 infections in mice and guinea pigsYo Hoshino, Sarat K Dalai, Kening Wang, et al.
The Journal of Infectious Diseases|February 3, 2005
The role of toll-like receptors in herpes simplex infection in neonatesEvelyn A Kurt-Jones, John Belko, Catherine Yu, et al.
Virology|June 24, 2016
Production of immunogenic West Nile virus-like particles using a herpes simplex virus 1 recombinant vectorTravis J Taylor, Fernando Diaz, Robert C Colgrove, et al.
Virology Journal|October 28, 2004
Persistent expression of chemokine and chemokine receptor RNAs at primary and latent sites of herpes simplex virus 1 infectionW James Cook, Martha F Kramer, Russell M Walker, et al.
Immunology|July 22, 2015
Combined cytotoxic activity of an infectious, but non-replicative herpes simplex virus type 1 and plasmacytoid dendritic cells against tumour cellsSabrina Thomann, Jan B Boscheinen, Karin Vogel, et al.
Journal of Virology|February 26, 2010
Numerous conserved and divergent microRNAs expressed by herpes simplex viruses 1 and 2Igor Jurak, Martha F Kramer, Joseph C Mellor, et al.
Virology|November 8, 2015
History and genomic sequence analysis of the herpes simplex virus 1 KOS and KOS1.1 sub-strainsRobert C Colgrove, Xueqiao Liu, Anthony Griffiths, et al.
Immunotherapy Advances|July 18, 2023
Blockade of innate inflammatory cytokines TNF<b>α</b>, IL-1<b>β</b>, or IL-6 overcomes virotherapy-induced cancer equilibrium to promote tumor regressionMichael J Walsh, Lestat R Ali, Patrick Lenehan, et al.
Pageof 16